187 related articles for article (PubMed ID: 31744495)
1. Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.
Hu YX; Zheng MJ; Zhang WC; Li X; Gou R; Nie X; Liu Q; Hao YY; Liu JJ; Lin B
J Transl Med; 2019 Nov; 17(1):379. PubMed ID: 31744495
[TBL] [Abstract][Full Text] [Related]
2. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
3. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Zhu J; Chen Z; Yong L
Gynecol Oncol; 2018 Feb; 148(2):368-374. PubMed ID: 29191436
[TBL] [Abstract][Full Text] [Related]
4. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
6. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Li X; Wang Y; Li B; Ma W
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
[TBL] [Abstract][Full Text] [Related]
8. Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Wu HY; Li QQ; Liang L; Qiu LL; Wei HW; Huang BY; Gang- C; He RQ; Huang ZG; Hou W; Hu QP; Pan SL
IET Syst Biol; 2020 Dec; 14(6):314-322. PubMed ID: 33399095
[TBL] [Abstract][Full Text] [Related]
9. Role of alternative splicing events in endometrial cancer prognosis.
Liu J; Mi C; Long W; Sun T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):680-688. PubMed ID: 34382583
[TBL] [Abstract][Full Text] [Related]
10. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
11. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
12. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
Liang B; Li Y; Wang T
Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
[TBL] [Abstract][Full Text] [Related]
13. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
14. Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Chen H; Deng Q; Wang W; Tao H; Gao Y
J Ovarian Res; 2020 Nov; 13(1):131. PubMed ID: 33160404
[TBL] [Abstract][Full Text] [Related]
15. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
16. Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y
DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082
[TBL] [Abstract][Full Text] [Related]
17. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
Zhang D; Zou D; Deng Y; Yang L
J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
[TBL] [Abstract][Full Text] [Related]
19. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
[TBL] [Abstract][Full Text] [Related]
20. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
